PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1904620-2	1991	Moclobemide belongs to a new class of substances called RIMA (Reversible Inhibitor of the monoamine oxidase type A).	rima	56-60	monoamine oxidase A	Homo sapiens	90-114	
1347658-3	1992	A new class of RIMA (Reversible Inhibitors of MAO-A) represented by moclobemide requires a change in clinical thinking on antidepressants.	rima	15-19	monoamine oxidase A	Homo sapiens	46-51	
1546143-1	1992	RIMA is a term for reversible inhibitors of monoamine oxidase (MAO) with preference for MAO-A; moclobemide is a prototype of this new class of antidepressants and is a highly selective inhibitor of MAO-A in vitro.	rima	0-4	monoamine oxidase A	Homo sapiens	88-93	
1546143-1	1992	RIMA is a term for reversible inhibitors of monoamine oxidase (MAO) with preference for MAO-A; moclobemide is a prototype of this new class of antidepressants and is a highly selective inhibitor of MAO-A in vitro.	rima	0-4	monoamine oxidase A	Homo sapiens	198-203	
7905288-1	1993	Moclobemide, p-chloro-N-[morpholinoethyl]benzamide, is a prototype of RIMA (reversible inhibitor of MAO-A) agents.	rima	70-74	monoamine oxidase A	Homo sapiens	100-105	
14697899-6	2004	The consequence of these findings were the development of reversible MAO-A inhibitors (RIMA), moclobemide and brofaromin, as antidepressants and possible anti-Parkinson activity, with limited tyramine potentiation, since the amine can displace the inhibitor from its binding site on the enzyme.	rima	87-91	monoamine oxidase A	Homo sapiens	69-74	
19890267-8	2010	Thus, CX157 is the first agent in the RIMA class with documented reversible inhibition of human brain MAO-A, supporting its classification as a RIMA, and the first RIMA with observed plasma levels that can serve as a biomarker for the degree of brain MAO-A inhibition.	rima	38-42	monoamine oxidase A	Homo sapiens	102-107	
2123366-1	1990	Moclobemide, a new selective and reversible inhibitor of monoamine oxidase A (RIMA), has been compared with various tricyclic antidepressants (TCAs) in numerous controlled studies.	rima	78-82	monoamine oxidase A	Homo sapiens	57-76	
32403270-3	2020	In this work, we aimed to find potential drugs for PCa patients suffering from depression by establishing novel anti-PCa reversible monoamine oxidase-A inhibitors (MAO-AIs/RIMA); with an endeavor to understand their mechanism of action.	rima	172-176	monoamine oxidase A	Homo sapiens	132-151	
10410765-1	1999	Moclobemide, the first reversible inhibitor of MAOA (so-called RIMA) to become widely available for clinical use, is an effective and well-tolerated antidepressant.	rima	63-67	monoamine oxidase A	Homo sapiens	47-51	
11294480-2	2001	This study examines the relation between baseline clinical characteristics in patients with posttraumatic stress disorder (PTSD) and response to treatment with a reversible monoamine oxidase A inhibitor (RIMA), brofaromine.	rima	204-208	monoamine oxidase A	Homo sapiens	173-192	
9273760-2	1997	Moclobemide is a reversible inhibitor of the monoamine oxidase type A (RIMA).	rima	71-75	monoamine oxidase A	Homo sapiens	45-69